Investigational immunotherapy nearly doubles overall survival compared with docetaxel in advanced squamous NSCLC
Medical Xpress 2 views
Topic timeline
How reporting on this topic developed over time — coverage by day, outlet counts, and multi-source storylines where they exist.
Coverage evolution
Not enough independent coverage yet to show how reporting developed. The facts below are direct observations from the tracked window.
Earliest in tracked window
Oldest report in the coverage window currently tracked for this topic.
Brain metabolism predicts survival in advanced non–small cell lung cancer patients Medical Xpress · Jul 28, 2026Latest update
Most recent tracked report from Medical Xpress.
Investigational immunotherapy nearly doubles overall survival compared with docetaxel in advanced squamous NSCLC Medical Xpress · 1h ago5 reports in date order. Not enough independent coverage yet to show a development timeline.